Over half a century, treatment of thyroid autonomy with an oral dose of iodine-131 has
proven to be effective. The optimum management strategy for the patient is, however, still a …

Aim The use of radioiodine therapy is common in the treatment of benign thyroid disease.
Council directive Euratom 97/43 requires that for all medical exposure of individuals for …

The recommended target dose in radioiodine therapy of solitary hyperfunctioning thyroid
nodules is 300-400Gy and therefore higher than in other radiotherapies. This is due to the …

A tissue‐specific dosimetric method based on gamma camera acquisitions was developed
to determine the activity to administer to patients with autonomous thyroid nodules (ATN) to …

Aim: We investigated whether additional application of “cold” iodine after therapy with
radioiodine could result in a prolongation of the effective half life of iodine-131 and would …

131I-Iodide is the treatment of choice in most cases of hyperthyroidism, with a standard
7,000-cGy (rad) thyroid absorbed dose generally resulting in an incidental blood absorbed …

Abstract Purpose 124 I-PET/CT can be used for pre-therapeutic assessment of radioactive
iodine uptake in benign thyroid disorders, however systematic comparisons with intra …

Due to its high success rate and non-invasive character, an increasing demand for
radioiodine therapy can be seen. This study was conducted to determine whether …

The development of hypothyroidism after the elimination of hyperthyroidism, inevitable as it
may be, does not per se necessitate the acceleration of this outcome. Even though death is …

Dear Sir, All agree that radioiodine therapy will remove hyperthyroidism caused by Graves'
and toxic nodular diseases. However, therapeutic dosing of radioioidine remains …